FN1 and neoplasm: Tumor and immunosuppressive cells could produce suppressive cytokines and metabolites and transduce suppressive signals to inhibit the survival and activation of anti-tumor immune cells [48], while physical barriers such as an excessive accumulation of collagen and fibronectin could limit the egress of anti-tumor immune cells to tumors [49].